Pro Share Advisors LLC Forma Therapeutics Holdings, Inc. Transaction History

Pro Share Advisors LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 01, 2022	SELL	$5.1 - $10.0 $57,502 - $112,750	-11,275 Closed	0 $0
Q1 2022 May 10, 2022	SELL	$8.34 - $14.69 $23,543 - $41,469	-2,823 Reduced 20.02%	11,275 $105,000
Q4 2021 Feb 08, 2022	SELL	$13.6 - $24.89 $5,140 - $9,408	-378 Reduced 2.61%	14,098 $200,000
Q3 2021 Nov 12, 2021	SELL	$21.22 - $25.7 $50,482 - $61,140	-2,379 Reduced 14.11%	14,476 $336,000
Q2 2021 Aug 13, 2021	BUY	$22.86 - $30.95 $58,841 - $79,665	2,574 Added 18.02%	16,855 $420,000
Q1 2021 May 14, 2021	BUY	$24.58 - $42.82 $101,269 - $176,418	4,120 Added 40.55%	14,281 $400,000
Q4 2020 Feb 09, 2021	BUY	$34.9 - $51.08 $354,618 - $519,023	10,161 New	10,161 $355,000

26.5K

Ticker FMTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,860,400
Market Cap $958M
Description
Forma Therapeutics Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on development and commercialization of novel therapeutics for treatment of rare hematologic diseases and cancers. Its core product candidates for development include FT-4202, which is Phase 1 trial for the treatment of sickle cell disease and other hemoglobin...

Get notified when there are updates to the investment portfolio of Pro Share Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Pro Share Advisors LLC with notifications on news.